With its combination of expert care, affordable pricing, and the allure of a vibrant cultural experience, Mexico continues to ...

CrazyBulk has long been recognized as a leader in natural, legal performance supplements. In 2025, the brand has solidified ...

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten ...

Closing of the private placement and the debt settlement is subject to customary closing conditions and the Company intends to close as soon as practicable. All of the securities will be subject to a ...

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® and the AYON Body ...

Wherley brings nearly a decade of executive leadership at VITAS to his new role. He has served as chief operating officer for the past eight years and assumed the role of president in 2024, overseeing ...

Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or ...

NASHVILLE, Tenn., July 30, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced two favorable oral abstracts, including one late-breaking, that will be ...

Lytus Fintech, a business unit of Lytus Technologies Holdings PTV Ltd. (OTCMKTS: LYTHF) today announced the launch of its integration and support of XRP with its flagship digital wallet platform NexFi ...

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing ...

TD Cowen and BMO Capital Markets are acting as joint book-running managers for the proposed offering.

Craig-Hallum Capital Group LLC is acting as the sole managing underwriter for the offering. Dyadic intends to use the net proceeds from the proposed offering for working capital and general corporate ...